VIC Foundry Receives NIH Grant for Development of Ultrafast Protein Biomarker Detection Instrument

“We are thrilled to receive NIH funding for this high-impact technology that can help researchers develop new diagnostics and treatments across a wide range of conditions,” said Calvin Goforth, CEO of VIC Foundry.

VIC Foundry, in collaboration with the University at Buffalo, received a $259,000 grant from the National Institutes of Health (NIH) under the Small Business Technology Transfer (STTR) program. STTR grants support research and development to reduce the risks associated with new technologies that have significant commercial potential.

The grant will help VIC Foundry develop a microwave microreactor for the in situ capture and digestion of target proteins, taking advantage of an extraordinary accelerating effect of a unique microwave resonator on binding rates and pyrolytic reaction. The microreactor can be coupled directly to mass spectrometry for ultra-fast (near real-time) and unambiguous detection of protein biomarkers.

“We are thrilled to receive NIH funding for this high-impact technology that can help researchers develop new diagnostics and treatments across a wide range of conditions,” said Calvin Goforth, CEO of VIC Foundry.

Proteins are the most important and established class of biomarkers for clinical diagnosis, monitoring and management. In the diagnosis, risk stratification and management of many life-threatening diseases/conditions such as myocardial infarction, every minute counts and the unambiguous detection of relevant protein biomarkers is crucial. Unfortunately, the workflow of the current approach – mass spectrometry – is hampered by the sample preparation process. Microwave reactor technology will address this important limitation.

The proposed technology and product will streamline the workflow of protein mass spectrometry analysis, free end users from multiple laborious and tedious sample preparation steps, and enable near real-time and unambiguous detection of protein biomarkers, as well as therapeutics, drug targets, and more.

About VIC Foundry

VIC Foundry is a part of the VIC innovation ecosystem which includes VIC Tech, VIC Investor Network and various associated programs such as VIC Fellows. VIC Foundry develops technologies that have substantial potential impact and commercial promise, but require further development before private equity funding. VIC Foundry further develops promising technologies by accessing various grant funding opportunities. After the grant-funded project is successfully completed, a new company is created, VIC places an initial management team, and the VIC investor network makes a founder investment in the newly created company. To learn more, visit vicfoundry.com

Share the article on social networks or by e-mail:

Comments are closed.